EPO--one year later. Part II. Balancing the costs and benefits
Nephrol News Issues
.
1990 Jun;4(6):22, 38.
Author
C Blagg
PMID:
2119485
No abstract available
MeSH terms
Cost-Benefit Analysis / economics
Costs and Cost Analysis / economics
Erythropoietin / therapeutic use*
Humans
Kidney Failure, Chronic / economics
Kidney Failure, Chronic / therapy
Renal Dialysis / economics
Substances
Erythropoietin